Halozyme Therapeutics shares owned by Campbell & Co. Investment Adviser
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Campbell & Co. Investment Adviser
from 13F filings
Historical chart of Campbell & Co. Investment Adviser investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Campbell & Co. Investment Adviser
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $1.9M | 39k | 47.81 |
| 2024-09-30 | $1.8M | 31k | 57.24 |
| 2024-03-31 | $1.4M | 34k | 40.68 |
| 2023-09-30 | $591k | 16k | 38.20 |
| 2023-03-31 | $1.3M | 34k | 38.19 |
| 2022-12-31 | $769k | 14k | 56.90 |
| 2022-09-30 | $819k | 21k | 39.52 |
| 2022-06-30 | $719k | 16k | 44.00 |
| 2021-09-30 | $450k | 11k | 40.67 |
| 2021-03-31 | $242k | 5.8k | 41.62 |
| 2020-12-31 | $214k | 5.0k | 42.67 |
| 2020-09-30 | $303k | 12k | 26.31 |
| 2020-06-30 | $399k | 15k | 26.81 |
| 2019-12-31 | $2.0M | 114k | 17.73 |
| 2013-06-30 | $335k | 42k | 7.94 |
More positions owned by Campbell & Co. Investment Adviser
View all positions for Campbell & Co. Investment Adviser